Range
12.2 - 13.04
Vol / Avg.
35.8K/87K
Div / Yield
-
52 Wk
6.9 - 15.89
Mkt Cap
283.6M
Payout Ratio
-
Open
12.84
P/E
-
EPS
-0.59
Shares
22.3M
Outstanding
22.3M
Total Float
9.9M
Impel NeuroPharma Inc is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. Its pipeline of proprietary product candidates includes INP107 for the treatment of OFF episodes in Parkinson's Disease.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-15
REV
Q1 2021Est.ActualSurprise
EPS-0.540
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
IMPLImpel NeuroPharma0%283.6M

Impel NeuroPharma Frequently Asked Questions

Q

How do I buy Impel NeuroPharma (IMPL) stock?

A

You can purchase shares of Impel NeuroPharma (NASDAQ: IMPL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Impel NeuroPharma's (IMPL) competitors?

A

There are no as such competitors for Impel NeuroPharma.

Q

What is the target price for Impel NeuroPharma (IMPL) stock?

A

The latest price target for Impel NeuroPharma (NASDAQ: IMPL) was reported by Guggenheim on May 18, 2021. The analyst firm set a price target for 32.00 expecting IMPL to rise to within 12 months (a possible 151.37% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Impel NeuroPharma (IMPL)?

A

The stock price for Impel NeuroPharma (NASDAQ: IMPL) is $12.73 last updated Today at 8:00:02 PM.

Q

Does Impel NeuroPharma (IMPL) pay a dividend?

A

There are no upcoming dividends for Impel NeuroPharma.

Q

When is Impel NeuroPharma (NASDAQ:IMPL) reporting earnings?

A
Impel NeuroPharma’s Q2 earnings are confirmed for after-market on August 15, 2021.
Q

Is Impel NeuroPharma (IMPL) going to split?

A

There is no upcoming split for Impel NeuroPharma.

Q

What sector and industry does Impel NeuroPharma (IMPL) operate in?

A

Impel NeuroPharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.